Arcellx Inc (ACLX)
53.28
+1.12
(+2.15%)
USD |
NASDAQ |
May 02, 16:00
53.28
0.00 (0.00%)
After-Hours: 20:00
Arcellx 1 Year Total Returns (Daily): 19.03% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | 19.03% |
| April 30, 2024 | 17.20% |
| April 29, 2024 | 19.75% |
| April 26, 2024 | 16.70% |
| April 25, 2024 | 25.32% |
| April 24, 2024 | 31.33% |
| April 23, 2024 | 37.61% |
| April 22, 2024 | 31.45% |
| April 19, 2024 | 46.48% |
| April 18, 2024 | 63.47% |
| April 17, 2024 | 56.17% |
| April 16, 2024 | 78.07% |
| April 15, 2024 | 83.68% |
| April 12, 2024 | 105.5% |
| April 11, 2024 | 109.0% |
| April 10, 2024 | 112.4% |
| April 09, 2024 | 106.8% |
| April 08, 2024 | 107.3% |
| April 05, 2024 | 126.3% |
| April 04, 2024 | 118.9% |
| April 03, 2024 | 115.2% |
| April 02, 2024 | 109.0% |
| April 01, 2024 | 117.4% |
| March 28, 2024 | 129.9% |
| March 27, 2024 | 134.8% |
| Date | Value |
|---|---|
| March 26, 2024 | 139.1% |
| March 25, 2024 | 134.7% |
| March 22, 2024 | 146.4% |
| March 21, 2024 | 140.1% |
| March 20, 2024 | 147.4% |
| March 19, 2024 | 145.1% |
| March 18, 2024 | 131.9% |
| March 15, 2024 | 141.1% |
| March 14, 2024 | 131.1% |
| March 13, 2024 | 155.4% |
| March 12, 2024 | 153.8% |
| March 11, 2024 | 155.7% |
| March 08, 2024 | 158.2% |
| March 07, 2024 | 156.2% |
| March 06, 2024 | 163.9% |
| March 05, 2024 | 146.8% |
| March 04, 2024 | 140.6% |
| March 01, 2024 | 138.7% |
| February 29, 2024 | 135.0% |
| February 28, 2024 | 140.3% |
| February 27, 2024 | 141.0% |
| February 26, 2024 | 131.3% |
| February 23, 2024 | 126.6% |
| February 22, 2024 | 118.3% |
| February 21, 2024 | 117.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
16.70%
Minimum
Apr 26 2024
471.4%
Maximum
May 18 2023
119.5%
Average
91.06%
Median
Aug 22 2023
1 Year Total Returns (Daily) Benchmarks
| Blueprint Medicines Corp | 84.19% |
| Alnylam Pharmaceuticals Inc | -25.71% |
| Ionis Pharmaceuticals Inc | 20.54% |
| Madrigal Pharmaceuticals Inc | -32.10% |
| Vertex Pharmaceuticals Inc | 16.57% |